Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | 1587 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | 3007 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | 3223 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | 5915 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | N | Exemestane | Black | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | N | Exemestane | Black | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | N | Exemestane | White | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | N | Exemestane | White | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | N | Exemestane | White | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | N | Letrozole | Black | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | N | Letrozole | White | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | N | Letrozole | White | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | N | Letrozole | White | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | N | Exemestane | Black | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | N | Exemestane | White | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | N | Letrozole | Black | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | N | Letrozole | White | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | N | Letrozole | White | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | N | Letrozole | White | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | Y | Exemestane | White | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | Y | Exemestane | White | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | Y | Letrozole | White | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | 1146 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | 1309 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | 1691 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | 2606 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | 2878 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | 3306 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | 4308 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | N | Exemestane | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | N | Exemestane | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+H)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 1011 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 1158 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 1200 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 1212 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 1226 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 1235 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 1241 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 1288 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 1414 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 1419 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 1580 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 1659 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 1682 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 1713 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 1840 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 1896 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 2049 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 2052 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 2129 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 2314 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 2367 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 2462 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 2492 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 2494 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 2529 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 2573 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 2733 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 2826 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 2889 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 2935 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 2947 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 3011 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 3095 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 3491 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 4452 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 5467 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 6001 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | 6414 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Case | N | Exemestane | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Case | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Case | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Case | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Case | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Case | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Case | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Case | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Case | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Case | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Control | N | Exemestane | Black | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Control | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Control | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Control | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Control | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Control | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Control | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Control | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Control | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M+NA)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |